{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:33:09Z","timestamp":1789644789908,"version":"4.0.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.clml.2024.05.008","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T16:40:59Z","timestamp":1715186459000},"page":"e293-e300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery Meet"],"prefix":"10.1016","volume":"24","author":[{"given":"Maria Magdalena","family":"Joks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Czernikiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Mazurkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Joks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Balcerzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Kroll-Balcerzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1585-6410","authenticated-orcid":false,"given":"Joanna","family":"Rupa-Matysek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0001","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/j.clml.2020.12.005","article-title":"Breast implant-associated anaplastic large cell lymphoma","volume":"21","author":"Alotaibi","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2024.05.008_bib0002","unstructured":"American Society of Plastic Surgeons. 2020 Plastic surgery statistics report. [Accessed: April 7, 2023] Available from: https:\/\/www.plasticsurgery.org\/documents\/News\/Statistics\/2020\/plastic-surgery-statistics-full-report-2020.pdf"},{"key":"10.1016\/j.clml.2024.05.008_bib0003","unstructured":"American Society of Plastic Surgeons. 2018 Plastic surgery statistics report. [Accessed: April 7, 2023] Available from: https:\/\/www.plasticsurgery.org\/documents\/News\/Statistics\/2018\/plastic-surgery-statistics-full-report-2018.pdf"},{"key":"10.1016\/j.clml.2024.05.008_bib0004","unstructured":"American Society of Plastic Surgeons. 2019 Plastic surgery statistics report. [Accessed: April 7, 2023] Available from: https:\/\/plasticsurgerycal.com\/wp-content\/uploads\/2021\/08\/plastic-surgery-statistics-full-report-2019.pdf"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.12701\/yujm.2020.00801","article-title":"Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)","volume":"38","author":"Lee","year":"2021","journal-title":"Yeungnam Univ J Med"},{"issue":"6","key":"10.1016\/j.clml.2024.05.008_bib0006","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/SAP.0000000000003330","article-title":"Outcomes analysis of textured versus smooth tissue expanders in breast reconstruction","volume":"89","author":"Di Valerio","year":"2022","journal-title":"Ann Plast Surg"},{"issue":"2","key":"10.1016\/j.clml.2024.05.008_bib0007","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","article-title":"Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant","volume":"100","author":"Keech","year":"1997","journal-title":"Plast Reconstr Surg"},{"issue":"20","key":"10.1016\/j.clml.2024.05.008_bib0008","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.clml.2024.05.008_bib0009","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthet Surg J"},{"issue":"Suppl_1","key":"10.1016\/j.clml.2024.05.008_bib0011","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/asj\/sjy331","article-title":"2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Clemens","year":"2019","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clml.2024.05.008_bib0012","unstructured":"BIA-ALCL Physician Resources. American Society of Plastic Surgeons. 2024. [Accessed: January 16, 2024] Available from: https:\/\/www.plasticsurgery.org\/for-medical-professionals\/health-policy\/bia-alcl-physician-resources"},{"key":"10.1016\/j.clml.2024.05.008_sbref0013","series-title":"Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma","year":"2023"},{"issue":"11","key":"10.1016\/j.clml.2024.05.008_bib0014","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/asj\/sjac133","article-title":"2022 practice recommendation updates from the world consensus conference on BIA-ALCL","volume":"42","author":"Santanelli di Pompeo","year":"2022","journal-title":"Aesthet Surg J."},{"issue":"9","key":"10.1016\/j.clml.2024.05.008_bib0015","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/asj\/sjaa285","article-title":"European Association of Plastic Surgeons (EURAPS) committee on device safety and development. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): review of epidemiology and prevalence assessment in Europe","volume":"41","author":"Santanelli di Pompeo","year":"2021","journal-title":"Aesthet Surg J"},{"issue":"5","key":"10.1016\/j.clml.2024.05.008_bib0016","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bjps.2019.11.064","article-title":"Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants","volume":"73","author":"Cordeiro","year":"2020","journal-title":"J Plast Reconstr Aesthetic Surg JPRAS"},{"issue":"11","key":"10.1016\/j.clml.2024.05.008_bib0017","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/asj\/sjad181","article-title":"BIA-ALCL epidemiology in an aesthetic breast surgery cohort of 1501 patients","volume":"43","author":"Kolasi\u0144ski","year":"2023","journal-title":"Aesthet Surg J"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0018","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/SLA.0000000000004179","article-title":"Breast implant-associated anaplastic large cell lymphoma incidence: determining an accurate risk","volume":"272","author":"Nelson","year":"2020","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.clml.2024.05.008_bib0019","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1182\/blood.2019004498","article-title":"Increased prevalence of BRCA1\/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast","volume":"136","author":"de Boer","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2024.05.008_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-018-0688-x","article-title":"Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report","volume":"13","author":"Pastorello","year":"2018","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.clml.2024.05.008_bib0021","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/CEJ.0000000000000809","article-title":"BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature","volume":"32","author":"Carbonaro","year":"2023","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.clml.2024.05.008_sbref0022","series-title":"Questions and Answers About Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)","year":"2023"},{"issue":"10","key":"10.1016\/j.clml.2024.05.008_bib0023","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/jcm10102082","article-title":"The state of the art about etiopathogenetic models on breast implant associated-anaplastic large cell lymphoma (BIA-ALCL): a narrative review","volume":"10","author":"Cuomo","year":"2021","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.clml.2024.05.008_bib0024","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/cancers14071650","article-title":"Anaplastic large cell lymphoma: molecular pathogenesis and treatment","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.clml.2024.05.008_bib0025","first-page":"942","article-title":"Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"47","author":"Rond\u00f3n-Lagos","year":"2021","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"Suppl_1","key":"10.1016\/j.clml.2024.05.008_bib0026","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/asj\/sjy250","article-title":"What cytokines can tell us about the pathogenesis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Kadin","year":"2019","journal-title":"Aesthet Surg J"},{"issue":"Suppl_1","key":"10.1016\/j.clml.2024.05.008_bib0027","first-page":"S14","article-title":"Genetics of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Oishi","year":"2019","journal-title":"Aesthet Surg J"},{"issue":"2","key":"10.1016\/j.clml.2024.05.008_bib0028","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/his.14666","article-title":"CA9 expression in breast implant-associated anaplastic large cell lymphoma presenting in a lymph node","volume":"81","author":"Oishi","year":"2022","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.clml.2024.05.008_bib0029","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2019.245860","article-title":"Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma","volume":"106","author":"Oishi","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2024.05.008_bib0030","article-title":"Increasing evidence for the association of breast implant-associated anaplastic large cell lymphoma and Li Fraumeni syndrome","volume":"2019","author":"Adlard","year":"2019","journal-title":"Case Rep Genet"},{"key":"10.1016\/j.clml.2024.05.008_bib0031","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.breast.2022.11.009","article-title":"Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL","volume":"66","author":"Longo","year":"2022","journal-title":"Breast Edinb Scotl"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0032","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.17194","article-title":"UK guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group","volume":"192","author":"Turton","year":"2021","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.clml.2024.05.008_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00266-019-01521-3","article-title":"Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and the textured breast implant crisis","volume":"44","author":"K Groth","year":"2020","journal-title":"Aesthetic Plast Surg"},{"issue":"7\u20138","key":"10.1016\/j.clml.2024.05.008_bib0034","first-page":"16531","article-title":"Breast implant-associated anaplastic large cell lymphoma as a late complication of breast implant placement: a report of 3 Polish cases","volume":"133","author":"Czernikiewicz","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.clml.2024.05.008_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2021.01.041","article-title":"Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients","volume":"148","author":"Campanale","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"1","key":"10.1016\/j.clml.2024.05.008_bib0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/PRS.0000000000008632","article-title":"Silent rupture of silicone gel breast implants: high-resolution ultrasound scans and surveys of 584 women","volume":"149","author":"Salzman","year":"2022","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2024.05.008_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1174173","article-title":"The evaluation of the delayed swollen breast in patients with a history of breast implants","volume":"13","author":"Keane","year":"2023","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0038","first-page":"609","article-title":"Breast implant-associated anaplastic large cell lymphoma: review and multiparametric imaging paradigms","volume":"40","author":"Sharma","year":"2020","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"issue":"1","key":"10.1016\/j.clml.2024.05.008_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3034-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients","volume":"147","author":"Adrada","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clml.2024.05.008_bib0040","series-title":"Familial Breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer","year":"2019"},{"issue":"10","key":"10.1016\/j.clml.2024.05.008_bib0041","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1200\/JCO.19.02778","article-title":"Best practices guideline for the pathologic diagnosis of breast implant-associated anaplastic large-cell lymphoma","volume":"38","author":"Jaffe","year":"2020","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"21","key":"10.1016\/j.clml.2024.05.008_bib0042","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.3390\/cancers15215128","article-title":"CD30 lateral flow and enzyme-linked immunosorbent assays for detection of BIA-ALCL: a pilot study","volume":"15","author":"Zeyl","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.clml.2024.05.008_bib0043","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1097\/PRS.0000000000005565","article-title":"Achieving reliable diagnosis in late breast implant seromas: from reactive to anaplastic large cell lymphoma","volume":"143","author":"Di Napoli","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.clml.2024.05.008_bib0044","first-page":"166","article-title":"Breast implant-associated anaplastic large cell lymphoma: a review","volume":"32","author":"Quesada","year":"2019","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"2","key":"10.1016\/j.clml.2024.05.008_bib0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0046","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/PRS.0000000000005910","article-title":"Gluteal implant-associated anaplastic large cell lymphoma","volume":"144","author":"Mendes","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0047","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000000985","article-title":"Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma","volume":"42","author":"Ferrufino-Schmidt","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.clml.2024.05.008_bib0048","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2011.08651.x","article-title":"Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)","volume":"153","author":"Dearden","year":"2011","journal-title":"Br J Haematol"},{"issue":"18","key":"10.1016\/j.clml.2024.05.008_bib0049","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":"Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study","volume":"30","author":"Pro","year":"2012","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10168","key":"10.1016\/j.clml.2024.05.008_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.clml.2024.05.008_bib0051","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpra.2022.08.008","article-title":"A systematic review of outcomes following breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"34","author":"Sharma","year":"2022","journal-title":"JPRAS Open"},{"key":"10.1016\/j.clml.2024.05.008_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107377","article-title":"PI3K\/AKT inhibitor BEZ-235 targets CCND2 and induces G1 arrest in breast implant-associated anaplastic large cell lymphoma","volume":"133","author":"Nagel","year":"2023","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.clml.2024.05.008_bib0053","doi-asserted-by":"crossref","first-page":"48","DOI":"10.14797\/mdcvj.1126","article-title":"A right atrial mass with fever and cutaneous nodules","volume":"18","author":"Gao","year":"2022","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"6","key":"10.1016\/j.clml.2024.05.008_bib0054","doi-asserted-by":"crossref","first-page":"NP445","DOI":"10.1093\/asj\/sjac005","article-title":"From breast implant to rough implant associated\u2013anaplastic large cell lymphoma (RIA-ALCL)","volume":"42","author":"Santanelli di Pompeo","year":"2022","journal-title":"Aesthet Surg J"},{"issue":"8","key":"10.1016\/j.clml.2024.05.008_bib0055","doi-asserted-by":"crossref","first-page":"NP352","DOI":"10.1093\/asj\/sjz142","article-title":"The first country to ban a type of breast implant linked to anaplastic large cell lymphoma","volume":"39","author":"Vaysse","year":"2019","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clml.2024.05.008_bib0056","doi-asserted-by":"crossref","unstructured":"Danino MA, Dao L, Retchkiman M, Matetsa E, Iezzoni J, Bou-Merhi JS. Analysis of Allergan's biocell implant recall in a major university breast center. Plast Reconstr Surg - Glob Open. 2020;8(6):e2906. doi: 10.1097\/GOX.0000000000002906","DOI":"10.1097\/GOX.0000000000002906"},{"issue":"3 Suppl 3","key":"10.1016\/j.clml.2024.05.008_bib0057","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1097\/SAP.0000000000003193","article-title":"Smooth versus textured tissue expander breast reconstruction: complications and efficacy","volume":"88","author":"McLaughlin","year":"2022","journal-title":"Ann Plast Surg"},{"issue":"2","key":"10.1016\/j.clml.2024.05.008_bib0058","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jdcr.2014.12.006","article-title":"Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab","volume":"1","author":"Hruska","year":"2015","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0059","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1016\/j.crohns.2012.07.025","article-title":"EBV-associated plasmablastic lymphoma in a patient with Crohn's disease after adalimumab treatment","volume":"7","author":"Liu","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.clml.2024.05.008_bib0060","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ccr3.1382","article-title":"Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma","volume":"6","author":"Alderuccio","year":"2018","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1016\/j.clml.2024.05.008_bib0061","first-page":"80","article-title":"Breast implant-associated anaplastic large cell lymphoma: a review with emphasis on the role of brentuximab vedotin","volume":"2","author":"Stack","year":"2020","journal-title":"J Cell Immunol"},{"issue":"6","key":"10.1016\/j.clml.2024.05.008_bib0062","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1097\/HS9.0000000000000501","article-title":"The successful use of neo adjuvant brentuximab vedotin in the treatment of BIA-ALCL","volume":"4","author":"Allchin","year":"2020","journal-title":"HemaSphere"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:28:15Z","timestamp":1724473695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2152265024001794"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.05.008","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery Meet","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}